Literature DB >> 9892091

Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.

J H Kim1, S H Lee, C H Rhee, S Y Park, J H Lee.   

Abstract

According to reported cytogenetic studies, there is a significant association between chromosomal aberrations and aggressiveness in meningiomas. With the method of restriction fragment length polymorphism analysis (RFLP), we examined tumor specific LOH on chromosome 17p and 22q in 30 cases of intracranial meningiomas. There were eight cases of meningiomas with aggressive characteristics, such as invasive meningioma, malignant meningioma, hemangiopericytic meningioma, and multiple meningiomas with central neurofibromatosis. Twenty-five of 30 cases (83%) were constitutionally heterozygous for at least one of the chromosome 22q DNA markers and sixteen of 25 informative cases (64%) displayed loss of heterozygosity (LOH). All of the 8 informative cases (100%) of meningiomas with aggressive characteristics, showed LOH on chromosome 22q whereas non-aggressive cases revealed LOH in eight of 17 informative cases (47%). At the loci on chromosome 17p, only two cases of malignant meningionas showed LOH. Our results suggest that the inactivations of putative tumor suppressor genes on chromosome 22q and 17p may correlate with aggressiveness and malignant transformation of meningiomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9892091     DOI: 10.1023/a:1006110812240

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.

Authors:  J P Dumanski; G A Rouleau; M Nordenskjöld; V P Collins
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

3.  Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.

Authors:  C T Fong; N C Dracopoli; P S White; P T Merrill; R C Griffith; D E Housman; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

Authors:  M Fujimoto; D W Fults; G A Thomas; Y Nakamura; M P Heilbrun; R White; J L Story; S L Naylor; K S Kagan-Hallet; P J Sheridan
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

5.  Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.

Authors:  S Mashiyama; Y Murakami; T Yoshimoto; T Sekiya; K Hayashi
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

6.  Allelic loss on chromosome 22 correlates with histopathological predictors of recurrence of meningiomas.

Authors:  M Sanson; S Richard; O Delattre; M Poliwka; J Mikol; J Philippon; G Thomas
Journal:  Int J Cancer       Date:  1992-02-01       Impact factor: 7.396

7.  p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

Authors:  D Fults; D Brockmeyer; M W Tullous; C A Pedone; R M Cawthon
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

8.  Interface between the meningioma and the brain.

Authors:  S Nakasu; A Hirano; J F Llena; T Shimura; J Handa
Journal:  Surg Neurol       Date:  1989-09

9.  Deletion mapping of the medulloblastoma locus on chromosome 17p.

Authors:  P H Cogen; L Daneshvar; A K Metzger; M S Edwards
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

10.  Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.

Authors:  C Raffel; F E Gilles; K I Weinberg
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

View more
  4 in total

1.  Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.

Authors:  M E Baser; T Y Poussaint
Journal:  J Med Genet       Date:  2005-06-24       Impact factor: 6.318

2.  Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.

Authors:  In Bok Chang; Byung Moon Cho; Seung Myung Moon; Se Hyuck Park; Sae Moon Oh; Seong Jin Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

3.  Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.

Authors:  Maria D Begnami; Mauricio Palau; Elisabeth J Rushing; Mariarita Santi; Martha Quezado
Journal:  Hum Pathol       Date:  2007-05-23       Impact factor: 3.466

4.  The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring.

Authors:  Conor S Gillespie; Abdurrahman I Islim; Basel A Taweel; Christopher P Millward; Siddhant Kumar; Nitika Rathi; Shaveta Mehta; Brian J Haylock; Nicola Thorp; Catherine E Gilkes; David D A Lawson; Samantha J Mills; Emmanuel Chavredakis; Jibril Osman Farah; Andrew R Brodbelt; Michael D Jenkinson
Journal:  J Neurooncol       Date:  2021-04-22       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.